Structure and molecular mechanism of action
The botulinum toxin type A molecule consists of two chains connected by a disulfide bond: a heavy chain (mass approx. 100 kDa) and a light chain (approx. 50 kDa). The blockade of synaptic transmission proceeds in several stages:
- Binding. The heavy chain interacts with specific receptors on the presynaptic membrane of nerve terminals.
- Penetration. The toxin enters the neuron via endocytosis.
- Proteolysis. Inside the cell, the light chain exhibits enzymatic activity (acts as a protease). Its targets are the proteins of the SNARE complex, which are responsible for the fusion of synaptic vesicles with the cell membrane. The toxin cleaves the presynaptic membrane proteins (SNAP-25 and syntaxin) and the vesicle membrane protein (synaptobrevin).
- Blockade. Due to the inability of vesicles to fuse with the membrane, the release of acetylcholine into the synaptic cleft becomes impossible.
Pharmacological effects
The drug acts at the level of the peripheral nervous system (the molecule does not cross the blood-brain barrier).
- Skeletal muscle. The reduction in mediator release causes peripheral paralysis (myorelaxation). Crucially, the release of trophic factors from vesicles is not impaired, so injections do not lead to complete muscle atrophy.
- Autonomic nervous system. Impulse transmission in cholinergic synapses is disrupted. Clinically, the most significant blockade is of sympathetic cholinergic fibers innervating sweat glands, which causes marked anhidrosis.
Production and standardization
Preparations (e.g., Botox, Dysport) are obtained from Clostridium botulinum cultures through fermentation, purification, and crystallization. They are available as a lyophilized powder for injection.
The composition includes a neurotoxin and hemagglutinin. The latter protects the toxin from degradation and limits its diffusion into adjacent tissues, localizing the effect.
Because the composition of preparations is variable, assessment of activity relies on biological standardization rather than chemical analysis. Activity is measured in mouse units (U). One unit is the amount of toxin that causes the death of 50% of mice (LD50) of a specific strain and weight within three days upon intraperitoneal administration.
Clinical application
Unlike toxic doses that cause paralysis of the respiratory muscles and death, therapeutic doses are extremely small and do not affect overall motor activity. The toxin concentrates at the injection site, then enters the systemic circulation and is rapidly metabolized.
1. Spastic conditions (intramuscular or subcutaneous)
- Indications: blepharospasm, strabismus, spasticity following strokes and central nervous system trauma, multiple sclerosis, cerebral palsy, dystonic syndromes (spasmodic torticollis, hemifacial spasm).
- Features: the effect lasts 4–6 months. Function recovers only after reinnervation (sprouting)—the outgrowth of new collateral nerve terminals.
2. Hyperhidrosis and cosmetology (intradermal)
- Indications: excessive sweating of the axillae, palms, soles (blockade of apocrine glands), as well as correction of mimic wrinkles.
- Features: duration of effect is 6–8 months.
Complications and contraindications
The use of botulinum toxin may be accompanied by adverse reactions:
- Local: pain and microhematomas at the injection site.
- Systemic: mild generalized weakness (lasts up to 1 week, more common with high doses).
- Specific: depend on the injection site (ptosis, lacrimation, dysphagia).
- Immunogenicity: antibody formation against the hemagglutinin complex is possible, which reduces therapeutic efficacy.
Absolute contraindications: myasthenia gravis (due to the risk of worsening weakness), pregnancy, and breastfeeding.
Briefly: answers to topical questions
Which drug classes enhance the effect of botulinum toxin?
- Aminoglycoside antibiotics (Aminoglycosidi)—enhance the effect of botulinum toxin due to the risk of potentiating the neuromuscular block; therefore, combining them with agents that cause skeletal muscle relaxation is prohibited.
- Skeletal muscle relaxants—concomitant use with botulinum toxin is prohibited due to mutual enhancement of the effect.
What are the clinical symptoms of systemic botulinum toxin poisoning?
- Initial stage—gastroenteritic syndrome.
- Full-blown stage (nervous system involvement)—ophthalmoplegic, bulbar, and myasthenic syndromes, as well as respiratory failure.
The heavy chain of the toxin acts as a "transporter" (ensuring binding and endocytosis), while the light chain acts as "scissors" (a protease), cleaving SNARE complex proteins.
Class and exam questions
Why does local administration of botulinum toxin not cause muscle atrophy?
The drug blocks only the release of acetylcholine. Meanwhile, the release of trophic factors from presynaptic membrane vesicles is preserved, which maintains the nutrition of the muscle tissue.
What causes the drug effect to wear off over time?
Muscle or gland function recovers due to sprouting (reinnervation)—the process of forming new collateral sprouts from the nerve terminal that re-form the synapse.
Does botulinum toxin affect the central nervous system?
No, the drug molecule is unable to cross the blood-brain barrier (BBB), so central effects are absent.
What else to study on this topic
- Pathogenesis of foodborne poisoning (botulism) and respiratory muscle paralysis
- Differences between botulinum toxin serotypes (A, B, F) and their clinical significance
- The mechanism of sprouting (reinnervation) at the cellular level
- Specifics of botulinum toxin interaction with aminoglycoside antibiotics
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete guidelines on "Botulinum Toxin" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section «Drugs acting on cholinergic synapses»
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.